NISH Publications

Amponsah-Dacosta, E., D. Hussey, G., Le Fleur-Bellerose, C., Copelyn, J., Ndiaye, S., Henaff, L., ... & Kagina, B. (2025). Transforming evidence-informed vaccine decision-making across Africa: Insights from three years of the annual vaccinology course for national immunisation technical advisory groups (AVCN). Wellcome Open Research, 10, 125. 
https://doi.org/10.12688/wellcomeopenres.23605.1 

Anderson, K., Eley, B. S., Rabie, H., Muloiwa, R., Nuttall, J., Frigati, L., Le Roux, D. M., Wessels, T., Murray, J., Mudaly, V., Sridhar, G., Ragone, L., Vannappagari, V., Euvrard, J., Boulle, A., & Davies, M. A. (2025). Hospitalisation incidence among young children living with HIV in the Western Cape, South Africa. Aids.  
https://doi.org/10.1097/qad.0000000000004156  

Ayouni, I., Githaiga, J. N., Amponsah-Dacosta, E., Kagina, B. M., & Muloiwa, R. (2025). Adapting the WHO Behavioural and Social Drivers of Vaccination (BeSD) Tools and Vaccination Attitudes Examination (VAX) Scale for Pregnant Women in South Africa: Insights from a Mixed-Methods Pilot Study.  
https://doi.org/10.20944/preprints202502.1281.v1 

Kadir, A., Stevens, A. J., Wise, P. H., & Muloiwa, R. (2025). No excuses - improving child public health outcomes in humanitarian settings requires reliable data. PLOS Glob Public Health, 5(3), e0004231. https://doi.org/10.1371/journal.pgph.0004231  

Muloiwa, R., & Forsyth, K. D. (2025). Closing the pertussis immunity gap: vaccine equity saves infant lives. Lancet Infectious Diseases.   
https://doi.org/10.1016/s1473-3099(25)00109-4  

Nguyen, P. N. T., Heininger, U., Muloiwa, R., von König, C. H. W., Hozbor, D., Ong-Lim, A., Tan, T. Q., & Forsyth, K. (2025). Pertussis in Southeast Asia: country-level burden and recommendations from the Global Pertussis Initiative. IJID Regions, 14, 100559.  
https://doi.org/10.1016/j.ijregi.2024.100559  

Van der Lecq, T., Rhoda, N., Jordaan, E., Seobi, T., Visser, L., Gilbert, C., Muloiwa, R., & Holmström, G. (2025). Screening for retinopathy of prematurity (ROP) in South Africa: data from a newly established prospective regional register. BMJ Open Ophthalmology, 10(1). 
https://doi.org/10.1136/bmjophth-2024-002036  

Abugrain, K., McCulloch, M. I., Muloiwa, R., Luyckx, V. A., & Buys, H. (2024). A 6-year review of acute post-streptococcal glomerulonephritis at a public children's hospital in Cape Town, South Africa. Pediatric Nephrology, 39(6), 1809-1816. https://doi.org/10.1007/s00467-023-06247-8  

Amponsah-Dacosta, E., Ratshisusu, L., Modise, L. M., Blose, N., Simani, O. E., Selabe, S. G., Kagina, B. M., & Muloiwa, R. (2024). Hepatitis A Seroprevalence Among HIV-Exposed and Unexposed Pediatric Populations in South Africa. Vaccines (Basel), 12(11).  
https://doi.org/10.3390/vaccines12111276  

Ayouni, I., Mbangiwa, T., Amponsah-Dacosta, E., Noll, S., Kagina, B. M., & Muloiwa, R. (2024). Acceptance and uptake of vaccines against tetanus, influenza, pertussis, and COVID-19 among pregnant and postpartum women in low- and middle-income countries: a systematic review and meta-analysis protocol. Systematic Reviews, 13(1), 227. https://doi.org/10.1186/s13643-024-02645-7  

Brink, A., Kgasi, A., Musyoki, A., Kagina, B., Feldman, C., Reddy, D., Du Toit, E., Kalanxhi, E., Meyer, J., Impalli, I., Schönfeldt, M., Sibanda, M., Schellack, N., Skosana, P., Essack, S., Dlamini, S., & Ramsamy, Y. (2024). Vaccines in the fight against antimicrobial resistance - perspectives from South Africa. South African Medical Journal, 114(9), e2111. https://doi.org/10.7196/SAMJ.2024.v114i9.2111  

Dias, J. V., Varandas, L., Gonçalves, L., & Kagina, B. (2024). Outcomes of childhood TB in countries with a universal BCG vaccination policy. The International Journal of Tuberculosis and Lung Disease, 28(6), 273-277. https://doi.org/10.5588/ijtld.23.0321  

Dias, J. V., Varandas, L., Gonçalves, L., & Kagina, B. M. (2024). An insight into the burden of drug-resistant tuberculosis in children. Acta Paediatrica, 113(4), 781-782. 
https://doi.org/10.1111/apa.17120  

Machona, M. S., Muloiwa, R., Porter, M., Peter, J., & Lehloenya, R. J. (2024). Advanced human immunodeficiency virus (HIV) does not affect ability to utilize lymphadenopathy in assessment of drug reaction with eosinophilia and systemic symptoms syndrome in HIV and tuberculosis: Prospective comparative study.  Journal of Allergy and Clinical Immunology: Global, 3(3), 100276.  
https://doi.org/10.1016/j.jacig.2024.100276  

Misra, R., Todd, G., Esterhuizen, J., Muloiwa, R., Peter, J., & Lehloenya, R. J. (2024). Stevens-Johnson syndrome and toxic epidermal necrolysis-associated dysgeusia: Natural history and association with dysosmia.  The Journal of Allergy and Clinical Immunology: In Practice, 12(2), 522-525.  
https://doi.org/10.1016/j.jaip.2023.10.036  

Olson-Chen, C., Swamy, G. K., Gonik, B., Forsyth, K., Heininger, U., Hozbor, D., von König, C. H. W., Chitkara, A. J., Top, K. A., Muloiwa, R., van der Schyff, M., & Tan, T. Q. (2024). The current state of pertussis vaccination in pregnancy around the world, with recommendations for improved care: Consensus statements from the Global Pertussis Initiative. International Journal of Gynecology & Obstetrics, 165(3), 860-869.  
https://doi.org/10.1002/ijgo.15311 

Patterson, J., Cleary, S., Norman, J. M., Van Zyl, H., Awine, T., Mayet, S., Kagina, B., Muloiwa, R., Hussey, G., & Silal, S. P. (2024). Modelling the Cost-Effectiveness of Hepatitis A in South Africa. Vaccines (Basel), 12(2), 116. https://doi.org/10.3390/vaccines12020116  

Shankar, M., Hartner, A. M., Arnold, C. R. K., Gayawan, E., Kang, H., Kim, J. H., Gilani, G. N., Cori, A., Fu, H., Jit, M., Muloiwa, R., Portnoy, A., Trotter, C., & Gaythorpe, K. A. M. (2024). How mathematical modelling can inform outbreak response vaccination. BMC Infectious Diseases, 24(1), 1371.  
https://doi.org/10.1186/s12879-024-10243-0  

Sume, G. E., Hasan, Q., Shefer, A., Henaff, L., Cavallaro, K. F., Tencza, C. B., Hadler, S. C., Sidy, N., Sardar, P., Kagina, B. M., & Hutin, Y. (2024). Region-wide assessment of National Immunization Technical Advisory Groups (NITAGs) using the NITAG Maturity Assessment Tool (NMAT) - Experience from the Eastern Mediterranean Region of the World Health Organization, 2023. Vaccine, 42(9), 2239-2245.  
https://doi.org/10.1016/j.vaccine.2024.02.058  

Ayouni, I., Amponsah-Dacosta, E., Noll, S., Kagina, B. M., & Muloiwa, R. (2023). Interventions to Improve Knowledge, Attitudes, and Uptake of Recommended Vaccines during Pregnancy and Postpartum: A Scoping Review. Vaccines (Basel), 11(12).  
https://doi.org/10.3390/vaccines11121733  

Buys, H., Kerbelker, T., Naidoo, S., Mukuddem-Sablay, Z., Nxumalo, Z., & Muloiwa, R. (2023). Doing more with less: The use of non-invasive ventilatory support in a resource-limited setting. PLoS One, 18(2), e0281552. https://doi.org/10.1371/journal.pone.0281552  

Chitkara, A. J., Balasubramanian, S., Choudhury, J., Dash, N., Forsyth, K., Heininger, U., Hozbor, D. F., Muloiwa, R., Tan, T., & von König, C. H. W. (2023). Pertussis in India: Past, Present, and Future. Indian Journal of Pediatrics, 90(4), 393-399. https://doi.org/10.1007/s12098-022-04384-w  

Ebrahim, S., Blose, N., Gloeck, N., Hohlfeld, A., Balakrishna, Y., Muloiwa, R., Gray, A., Parrish, A., Cohen, K., Lancaster, R., & Kredo, T. (2023). Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years: A systematic review and meta-analysis. PLOS Global Public Health, 3(12), e0002676. https://doi.org/10.1371/journal.pgph.0002676  

Gebremicael, M. N., Nuttall, J. J. C., Tootla, H. D., Khumalo, A., Tooke, L., Salie, S., Muloiwa, R., Rhoda, N., Basera, W., & Eley, B. S. (2023). Candida bloodstream infection among children hospitalised in three public-sector hospitals in the Metro West region of Cape Town, South Africa. BMC Infectious Diseases, 23(1), 67.  
https://doi.org/10.1186/s12879-023-08027-z  

Manga, N., Amponsah-Dacosta, E., Hussey, G., Muloiwa, R., & Kagina, B. M. (2023). Expanding the reach of vaccinology training in Africa: leveraging the success of the Annual African Vaccinology Course. Frontiers in Health Service, 3, 1119858. https://doi.org/10.3389/frhs.2023.1119858  

Morgan, N., Buys, H., & Muloiwa, R. (2023). RSV infection in children hospitalised with severe lower respiratory tract infection in a low-middle-income setting: A cross-sectional observational study. PLoS One, 18(9), e0291433. https://doi.org/10.1371/journal.pone.0291433  

Okpokoro, E., Lesosky, M., Osa-Afiana, C., Bada, F., Okwor, U., Odonye, G., Igbinomwanhia, V., Abdurrahman, S., Medugu, N., Kagina, B., Abimiku, A., & Adams, S. (2023). Prevalence and Risk Factors for Mycobacterium tuberculosis Infection among Health Workers in HIV Treatment Centers in North Central, Nigeria. American Journal of Tropical Medicine and Hygiene, 109(1), 60-68. 
https://doi.org/10.4269/ajtmh.22-0531  

Pilic, A., Reda, S., Jo, C. L., Burchett, H., Bastías, M., Campbell, P., Gamage, D., Henaff, L., Kagina, B., Külper-Schiek, W., Lunny, C., Marti, M., Muloiwa, R., Pieper, D., Thomas, J., Tunis, M. C., Younger, Z., Wichmann, O., & Harder, T. (2023). Use of existing systematic reviews for the development of evidence-based vaccination recommendations: Guidance from the SYSVAC expert panel. Vaccine, 41(12), 1968-1978. 
https://doi.org/10.1016/j.vaccine.2023.02.027  

Shapaka, J. T., Muloiwa, R., & Buys, H. (2023). Association of full blood count findings with risk of mortality in children with Klebsiella pneumoniae bloodstream infection at a South African children's hospital. BMC Pediatrics, 23(1), 302. https://doi.org/10.1186/s12887-023-04104-z  

Shaver, N., Katz, M., Darko Asamoah, G., Linkins, L. A., Abdelkader, W., Beck, A., Bennett, A., Hughes, S. E., Smith, M., Begin, M., Coyle, D., Piggott, T., Kagina, B. M., Welch, V., Colijn, C., Earn, D. J. D., El Emam, K., Heffernan, J., O'Brien, S. F.,…Little, J. (2023). Protocol for a living evidence synthesis on variants of concern and COVID-19 vaccine effectiveness. Vaccine, 41(43), 6411-6418.  
https://doi.org/10.1016/j.vaccine.2023.09.012 

Abu-Raya, B., Forsyth, K., Halperin, S. A., Maertens, K., Jones, C. E., Heininger, U., Hozbor, D., Wirsing von König, C. H., Chitkara, A. J., Muloiwa, R., & Tan, T. Q. (2022). Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis Initiative. Vaccines (Basel), 10(12).  
https://doi.org/10.3390/vaccines10121990  

Aliyu, A. S., Masu, A. N., Kagina, B. M., & Muloiwa, R. (2022). The burden of human coronavirus infection in children hospitalised with lower respiratory tract infection in Cape Town, South Africa. medRxiv, 2022.2007. 
https://doi.org/10.1101/2022.07.24.22277967 

Argaw, M. D., Desta, B. F., Tsegaye, Z. T., Mitiku, A. D., Atsa, A. A., Tefera, B. B., Rogers, D., Teferi, E., Abera, W. S., Beshir, I. A., Kora, Z. A., Setegn, S., Anara, A. A., Sinamo, T., & Muloiwa, R. (2022). Immunization data quality and decision making in pertussis outbreak management in southern Ethiopia: a cross sectional study. Archives of Public Health, 80(1), 49. https://doi.org/10.1186/s13690-022-00805-6  

Blose, N., Amponsah-Dacosta, E., Kagina, B. M., & Muloiwa, R. (2022). Descriptive analysis of routine childhood immunisation timeliness in the Western Cape, South Africa. Vaccine X, 10, 100130. https://doi.org/10.1016/j.jvacx.2021.100130  

DeAtley, T., Harrison, A., Mtukushe, B., Maughan-Brown, B., Muloiwa, R., Hoare, J., Galárraga, O., & Kuo, C. (2022). Conditional Economic Incentives for HIV Treatment Adherence: Aligning Adolescent Developmental Hallmarks with Behavioral Economic Theory to Improve HIV Treatment Adherence. AIDS Patient Care and STDS, 36(7), 272-277. https://doi.org/10.1089/apc.2022.0060  

Dochez, C., & Kagina, B. M. (2022). Editorial: Advances in adolescent vaccination programs in Low- and Middle-Income Countries (LMICs): A focus on HPV vaccination capacity strengthening. Front Public Health, 10, 971578. https://doi.org/10.3389/fpubh.2022.971578  

Kagina, B. M. (2022).  Vaccinations prevent diseases and, at the same time, help to reduce poverty.  D+C Digital Monthly,  
19-20.  
https://www.dandc.eu/sites/default/files/print-editions/dc_2022-04_0.pdf 

Kagina, B. M., & Dochez. (2022). Editorial:  COVID-19 vaccine-induced immunity: Head-to-head comparison of mRNA (BNT162b2) versus inactivated (CoronaVac) vaccines. Respirology. 27(4),260–1.  
https://doi.org/10.1111/resp.14236 

Patterson, J., Cleary, S., Silal, S. P., Hussey, G. D., Enoch, A., Korsman, S., Goddard, E., Setshedi, M., Spearman, W. C., & Kagina, B. M. (2022). A retrospective study assessing the clinical outcomes and costs of acute hepatitis A in Cape Town, South Africa. BMC infectious diseases, 22(1), 45.  
https://doi.org/10.1186/s12879-021-06993-w 

Patterson, J., Cleary, S., van Zyl, H., Awine, T., Mayet, S., Norman, J., Kagina, B., Muloiwa, R., Hussey, G., & Silal, S. (2022). Modelling the cost-effectiveness of hepatitis A vaccination in South Africa. medRxiv, 2022.2010. 
https://doi.org/10.1101/2022.10.03.22280656 

Anderson, K., Kalk, E., Madlala, H. P., Nyemba, D. C., Kassanjee, R., Jacob, N., Slogrove, A., Smith, M., Eley, B. S., Cotton, M. F., Muloiwa, R., Spittal, G., Kroon, M., Boulle, A., Myer, L., & Davies, M. A. (2021). Increased infectious-cause hospitalization among infants who are HIV-exposed uninfected compared with HIV-unexposed. Aids, 35(14), 2327-2339. https://doi.org/10.1097/qad.0000000000003039  

Chepkurui, V., Amponsah-Dacosta, E., Haddison, E. C., & Kagina, B. M. (2021). Characterization of National Immunization Programs in the Context of Public Health Emergencies: A Case Study of 13 Countries in the WHO Africa Region. Frontiers in Public Health, 9, 736532. 
https://doi.org/10.3389/fpubh.2021.736532  

Majiet, M. I., Haddison, E. C., Amponsah-Dacosta, E., Hussey, G. D., Muloiwa, R., & Kagina, B. M. (2021). Human vaccine and immunisation research in South Africa: A bibliometric study. South African Medical Journal, 111(7), 649-654. https://doi.org/10.7196/SAMJ.2021.v111i7.15120